Protein Labeling Market Scope
Biological research often requires the use of molecular labels that are covalently connected to a protein of interest to facilitate detection of the labelled protein and its binding partners. Protein labelling relates to the use of the relevant molecular labels to identify the labelled protein and its binding partners, there are a lot of molecular labels and labelling strategies available. These technologies give an innovative alternative to traditional fluorescent proteins for studying the function and localization of proteins in living and fixed cells labelling strategies result in the covalent attachment of distinct molecules, including biotin, reporter enzymes, radioactive isotopes, and fluorophores to the target protein or nucleotide sequence. According to the research, protein labelling is necessary for biological research in proteomics and 84% of researchers are examining for conjugation ready solutions.
The Protein Labeling market study is segmented by Type (Reagents, Kits and Services), by Application (Cell-based Assays, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry and Protein Microarray) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Protein Labeling market throughout the predicted period.
Thermo Fisher Scientific, Inc. (United States), Merck KGaA (Germany), PerkinElmer, Inc. (United States), General Electric Company (United States), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs (United States), Kaneka Corporation (Japan), Promega Corporation (United States), LI-COR, Inc. (United States) and SeraCare Life Sciences, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Fluidic Analytics Ltd (United States) and Abcam (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
AMA Research has segmented the market of Global Protein Labeling market by Type, Application and Region.
On the basis of geography, the market of Protein Labeling has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In November 2020 Abcam announces a global innovator in life science reagents and tools announces successful acquisition of Expedeon’s Proteomics and Immunology business, enhancing its conjugation capability
In February 2020 Fluidic Analytics Ltd, a pioneer in protein analysis launches rapid, easy-to-use protein labelling kit, the new kit can be used with a multitude of techniques including the company’s groundbreaking Fluidity One-W instrument for protein interaction analysis
Market Trend
- Increase in adoption of bioengineering techniques
Market Drivers
- Augmenting Proteomics Research
- The rise in R&D Spending
Opportunities
- Emerging demand from developing regions
Restraints
- Lack of Skilled Professionals
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Protein Labeling Provider, Government Regulatory and Research Organizations and End-Use Industry